 |
| January
30, 2026 |
| Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
|
* may need subscription to view |
- ALX Oncology: New Data Demonstrate CD47
Expression Level Helps Predict Response to
Evorpacept in Combination With Ziihera
(zanidatamab-hrii) in Advanced HER2-Positive
Breast Cancer More
- Quince Therapeutics: Topline Results From
Pivotal Phase 3 NEAT Clinical Trial of eDSP
in Ataxia-Telangiectasia
More
- Unicycive Therapeutics: FDA Acceptance of
Oxylanthanum Carbonate (OLC) New Drug
Application (NDA) Resubmission More
More*
|
|
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- Aligos Therapeutics: Inducement Grants Under
Nasdaq Listing Rule 5635(c)(4) More
- ALX Oncology: Pricing of Underwritten
Offering More
- BioMarin: Pricing of Private Offering of
Senior Notes and Completion of Syndication of
New Senior Secured Term Loan Facility More
- CIRM: Approves New $100 Million Plan to
Accelerate Genetic Therapies for Patients With
Rare Diseases More
More
- Exclusive VC Funding Data from BYTE51,
with Special Big4Bio Pricing More
- LSN: Hot Investor Mandates (Updated 01/27) More
- Scilex: $20 Million Strategic Investment in
Quantum Scan Holdings, Inc., Targeting
Trillion-Dollar Preventive Diagnosis and
Prognosis Markets More
- Vaxcyte: Pricing of $550 Million Public
Offering More
|
|
 |
 |
| San
Francisco's most flexible contract
vivarium lab space: Start with a
few cages and grow. |
|
Learn More
→ |
|
|
- BioPharmGuy News: Biotech Magic, Funding
Folly, He's Crazy, Vaccines in Retrograde More
- Reed Jobs’ Cancer Biotech Investment Firm
Yosemite Eyes $350M Fund More*
- Sanofi Keeps Mum on Future of Disappointing
Denali Pact After Scrapping Final RIPK1
Inhibitor More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The Big4Bio Podcast: Every Moment
Matters: Getting Better Insights on Target
and off Target Biology Mark Aspinall and Jim
Raymond Podcast
- ‘We Don’t Stop’: How a New Owner is Turning
Around a Former Genentech Site More*
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: SFBay Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
| Apply
to have your company
showcased by Big4Bio |
|
|
|
|
|
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- BioSpace Reveals Fresh Design With 2026
Hotbed Maps, Highlighting Life Sciences Hubs More
- Former FDA Deputies Land at Lilly, AbbVie;
Italy’s Angelini Has a New CEO More*
- From Seed to Series C: What
Investors Look for Beyond the Science More
- ICYMI: CEO’s Perspective: Big Moves Come
with Big Responsibility More
- ICYMI: CEO’s Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- M&A in Life Sciences: The Turning Tide –
Why Now is a Strategic Inflection for
Biopharma and Biotech More
- The Rise of Fractional Talent in Life
Sciences: What to Expect in 2026 More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:SFBay,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
